Cycurion Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $14.4M-19.0% YoYTTM through 30 Jun 2026
Net Income -$14.1M-1,247.7% YoYTTM through 30 Jun 2026
Free Cash Flow -$12.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 10.7% |
| EBITDA Margin | -95.7% |
| Operating Margin | -154.6% |
| Net Margin | -98.0% |
Returns
-61.9%ROE
-36.8%ROA
Balance Sheet Health
Debt / Equity0.13x
Current Ratio0.30x
Net Debt$3M
Cash & Equivalents$1.9M
Quality Metrics
Altman Z-Score0.05
Piotroski F-Score1 / 9
FCF Margin-86.3%
Rule of 40-74.1
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $15.1M
Diluted EPS-$2.20TTMFY2025: $-13.42
Dividend
No dividend
Capital Allocation
R&D Spend$0
Capex Intensity3.3%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.